Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The AAPS Journal|March 8, 2011
Summary of confirmation cut point discussionsHolly W Smith, Michael Moxness, Robin Marsden
Bioanalysis|March 23, 2011
Bioanalytical considerations in the comparability assessment of biotherapeuticsJean W Lee, Yow-Ming Wang, Michael Moxness, et al.
Pediatric Neurology|August 10, 2005
Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapyMichael R Pranzatelli, Kelly Y Chun, Michael Moxness, et al.
The AAPS Journal|July 24, 2009
A step-wise approach for transfer of immunogenicity assays during clinical drug developmentSuzanna Tatarewicz, Michael Moxness, Dohan Weeraratne, et al.
Plos One|August 6, 2016
Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based BiotherapeuticsMarisa K Joubert, Meghana Deshpande, Jane Yang, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Journal of Immunological Methods|February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsEugen Koren, Holly W Smith, Elizabeth Shores, et al.
Pageof 1